ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.

November 29, 1996